ClinicalTrials.gg
Not yet recruitingNCT07316335Updated Jan 5, 2026

The Effect of Cognitive Behavioral Model-Based Psychoeducation on Social Exclusion, Hopelessness, and Relapse Levels in Individuals Diagnosed With Substance Use Disorder

An interventional study of Cognitive Behavioral Therapy (CBT) Theoretical Basic Training Group in Substance Use Disorder (SUD), sponsored by Ataturk University. Not yet recruiting. Open to participants aged 18 Weeks and older. Per ClinicalTrials.gov, last updated 2026-01-05.

Sponsored by Ataturk University · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Primary completion was expected by Mar 2026, 8 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
44
Allocation
Randomized
Ages
18 Weeks and older
Sex
All
01

Study summary

This research was planned to measure the effect of cognitive behavioral model-based psychoeducation on the level of social exclusion and hope in individuals diagnosed with substance use disorder, as well as teaching them to cope with the relapses they struggle with.

Read the detailed description

Substance addiction is a problem that all societies in the world are exposed to and is increasing in society.It is a serious public health problem. Substance use disorder affects individuals despite the negative consequences in bio-psycho-social areas, people continue to use psychoactive substances.a brain that continues with cravings, cravings for substance use, remissions, and relapses is the disease. There are many problems that continue with relapses and vary depending on the individual's addiction process. In the treatment of problematic substance use disorders, in addition to pharmacological treatment, psychotherapy and psychosocial approaches in which the person can actively participate Adding it to the treatment increases the success rate of the treatment. Psychosocial in substance addiction cognitive behavioral model-based approach, one of the intervention programs, It appears as one of the preferred intervention programs for addicts. Relapse prevention based on cognitive behavioral foundations developed by Marlatt and Gordon relapse prevention program helps reduce the risk of relapse in conditions such as substance use disorders focuses. This program includes various cognitive-behavioral skills that can be effective at different stages of the process. includes approaches. These approaches aim to increase individuals' hopes and improve their social skills.

It aims to develop and strengthen skills in coping with high-risk situationsProgram, It includes strategies that will help individuals regain their self-confidence. This, to ensure that individuals do not despair during the recovery process and that their motivation remains high.

supports their retention. Individuals are healthier and more effective in social interactions and relationships.

aims to communicate. Developing social skills as well as strengthening support systems It also focuses on supporting positive social interactions. The program allows individuals to It offers strategies to help students cope with high-risk situations associated with their use. This skills to cope with situations, the risk of falling behind when faced with risky situations, can reduce it. This relapse prevention program enables individuals to achieve sustainable improvement throughout the treatment process. While helping them achieve their goals, it also aims to minimize the risk of falling behind.

Integration of cognitive behavioral approaches, individuals' healthy lifestyle choices It supports them to become aware of and strengthen these choicesIn this way, they are more likely to learn to cope with and sustain chronic conditions such as substance use disorders.

becomes.

02

Conditions studied

  • Substance Use Disorder (SUD)

Keywords

  • Psychoeducation based on cognitive behavioral model
  • substance use disorder
  • hope
  • social exclusion
03

In context

Substance-Related Disorders

2,238 studies on the registry are indexed under Substance-Related Disorders; 409 are open to participants now.

This study's planned enrollment of 44 is below the median of 108 across 1,840 interventional studies indexed under Substance-Related Disorders.

Browse Substance-Related Disorders studies →

Lead sponsor

Ataturk University is the lead sponsor of 458 studies on the registry; 124 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Weeks and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Being between the ages of 18 and 65,
  2. Being diagnosed with substance use disorder according to ,
  3. Absence of comorbid diagnosis (bipolar disorder, anorexia/bulimia nervosa, psychotic symptoms)

Exclusion criteria

Exclusion Criteria:

  1. People experiencing acute exacerbations
  2. People who continue to use alcohol or substances
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

DSM diagnostic criteria

The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
44 participants (estimated)

Study arms

  • Experimental
    experimental group

    Before starting the program, the researcher received a Cognitive Behavioral Therapy (CBT) Theoretical Basic Training certificate. During the preparation of the Cognitive Behavioral Model-Based Psychoeducation Program, first of all, studies in the literature and books on the subject were examined, using both domestic and international sources. While creating training topics, the Cognitive Behavioral Model, which includes various cognitive and behavioral approaches designed to achieve the goal at each stage of the relapse process, was used. Each psychoeducation session will focus on planned topics such as informing patients about substance addiction, teaching them how to cope with high-risk situations, providing skills that can prevent relapses, providing impulse management, teaching stress coping skills, and increasing hope. Before starting the application, expert opinions will be presented and arrangements will be made in line with the suggestions.

    Behavioral: Cognitive Behavioral Therapy (CBT) Theoretical Basic Training Group

  • No intervention
    control group

    The control group will not be given any training or information during this period. They will continue their normal routines and treatments in daily life. After the training process ends, a post-test will be applied to the control group. After the study is completed, psychoeducation will be given to the control group if they request.

Interventions

  • BehavioralCognitive Behavioral Therapy (CBT) Theoretical Basic Training Group

    It was planned to measure the effect of cognitive behavioral model-based psychoeducation on the level of social exclusion and hope in individuals diagnosed with substance use disorder, as well as teaching them to cope with the relapses they struggle with.

06

What researchers measure

Primary outcomes

  1. implementation of psychoeducation based on the cognitive behavioral model - Social Exclusion Level

    Outcome Measure: Social Exclusion Scale Description: The Social Exclusion Scale will be used to assess participants' levels of exclusion from social relationships and withdrawal from social participation. Total scale scores will be used for quantitative analysis. The minimum and maximum possible scores and the interpretation of higher scores (indicating greater or lower levels of social exclusion) will be specified in the data analysis plan.

    Time frame: 16 weeks

  2. implementation of psychoeducation based on the cognitive behavioral model - Hopelessness Level

    Outcome Measure: Beck Hopelessness Scale (BHS) Description: The Beck Hopelessness Scale will be used to measure participants' levels of hopelessness. Total scores obtained from the scale will reflect the severity of hopelessness. The minimum and maximum possible scores and the interpretation that higher scores indicate higher levels of hopelessness

    Time frame: 16 weeks

Secondary outcomes

  1. Relapse Coping Skills Scale

    1\. Relapse Coping Level Outcome Measure: Relapse Coping Skills Scale Description: Participants' levels of coping with relapse will be assessed using a structured scale or subscale designed to evaluate relapse coping skills. Total scores obtained from the scale will be used to reflect participants' levels of relapse coping. The score range and interpretation of higher scores will be specified in the data analysis plan.

    Time frame: 8 weeks

  2. Substance Use Coping Strategies Scale

    2\. Substance Use Coping Strategies Outcome Measure: Substance Use Coping Strategies Scale Description: Coping strategies related to substance use will be assessed using a psychometric scale measuring cognitive and behavioral coping skills. Outcomes will be analyzed based on total scale scores, reflecting participants' use of adaptive coping strategies.

    Time frame: 8 weeks

07

Study locations

No study locations are listed for this record.

08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jan 2026; primary completion for Mar 2026, 1 month later.

Of 814 non-industry interventional studies with no phase under Substance-Related Disorders, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 53. This study's planned 1 month is below that.

Counting every sponsor, half of 854 studies reached it within 34 months; a quarter within 17 and three quarters within 53.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 25, 2025
First posted
Jan 5, 2026
StartEst.
Jan 30, 2026
Primary completionEst.
Mar 1, 2026
CompletionEst.
Sep 1, 2026
Last update
Jan 5, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 5, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07316335
Lead sponsor
Ataturk University
Responsible party
Seyma Laloglu (specialist nurse, Ataturk University) — Principal investigator
First posted
Jan 5, 2026
Start date
Jan 30, 2026 (estimated)
Primary completion
Mar 1, 2026 (estimated)
Completion
Sep 1, 2026 (estimated)
Last update
Jan 5, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion